BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11713757)

  • 1. Gene therapy using hematopoietic stem cells.
    Kohn DB
    Curr Opin Mol Ther; 1999 Aug; 1(4):437-42. PubMed ID: 11713757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress towards hematopoietic stem cell gene therapy.
    Kurre P; Kiem HP
    Curr Opin Mol Ther; 2000 Aug; 2(4):400-11. PubMed ID: 11249770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
    Neschadim A; McCart JA; Keating A; Medin JA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of gene therapy for hematopoietic stem cell using viral vectors].
    Dong WJ; Zu ZX; Liu DP; Liang CC
    Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer into hematopoietic progenitor and stem cells: progress and problems.
    Dunbar CE; Emmons RV
    Stem Cells; 1994 Nov; 12(6):563-76. PubMed ID: 7881358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
    Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
    Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
    Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
    Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for hematopoietic and immune disorders.
    Kohn DB
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S55-8. PubMed ID: 8971410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular gene therapy.
    Lee JH; Klein HG
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):91-113. PubMed ID: 7737946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on gene therapy for hereditary hematological disorders.
    Herzog RW; Arruda VR
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):215-32. PubMed ID: 15030282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons.
    Horn PA; Morris JC; Bukovsky AA; Andrews RG; Naldini L; Kurre P; Kiem HP
    Gene Ther; 2002 Nov; 9(21):1464-71. PubMed ID: 12378409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted gene modification for gene therapy of stem cells.
    Boggs SS
    Int J Cell Cloning; 1990 Mar; 8(2):80-96. PubMed ID: 1968938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells.
    Zhang J; Attar E; Cohen K; Crumpacker C; Scadden D
    Gene Ther; 2005 Oct; 12(19):1444-52. PubMed ID: 15877047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
    Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
    Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus.
    Schambach A; Schiedlmeier B; Kühlcke K; Verstegen M; Margison GP; Li Z; Kamino K; Bohne J; Alexandrov A; Hermann FG; von Laer D; Baum C
    Gene Ther; 2006 Jul; 13(13):1037-47. PubMed ID: 16541120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P; Arumugam PI; Yee JK; Puthenveetil G
    Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US panel advises resumption of gene trials.
    Fox JL
    Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.